B. D. Dávila Saldaña

发表

Tap water: A possible source of nontuberculous mycobacterial infection in patients with T cell deficiency.

B. Hanisch, M. Keller, Xiaoyan Song, 2019, American journal of infection control.

Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution

L. Notarangelo, J. Puck, S. S. De Ravin, 2021, The Journal of allergy and clinical immunology.

High Rates of Community and Hospital Acquired Infections in Patients with Cellular Immunodeficiencies

B. Hanisch, M. Keller, Xiaoyan Song, 2018, Journal of Clinical Immunology.

Chronic norovirus infection in primary immune deficiency disorders: an international case series.

N. Patel, S. Jolles, C. Dvorak, 2019, Diagnostic microbiology and infectious disease.

Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report.

L. Notarangelo, H. Ochs, J. Puck, 2020, Blood.

Primary Immunodeficiencies and Hematologic Malignancies: A Diagnostic Approach

N. Wright, S. Chandra, B. D. Dávila Saldaña, 2022, Frontiers in Immunology.

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

H. Heslop, C. Bollard, D. Hagin, 2021, Blood advances.

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.

E. Leifer, H. Deeg, P. Westervelt, 2022, The Lancet. Haematology.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of Clinical Immunology.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of clinical immunology.

Familial hemophagocytic lymphohistiocytosis in a newborn presenting with recurrent fever and thrombocytopenia

C. Dandoy, Hongsheng Wang, Wenhao Zhou, 2019, Pediatric Medicine.

Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case‐based review

T. Torgerson, D. Buchbinder, S. Chandrakasan, 2019, Pediatric blood & cancer.

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

L. Notarangelo, J. Puck, K. Sullivan, 2017, Blood.

Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC.

L. Notarangelo, J. Puck, T. Torgerson, 2022, Blood.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

L. Notarangelo, J. Puck, K. Sullivan, 2018, Blood.

B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

L. Notarangelo, J. Walter, J. Puck, 2018, Blood.

Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency

A. Schulz, L. Notarangelo, C. Picard, 2021, Frontiers in Immunology.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

L. Notarangelo, J. Walter, J. Puck, 2020, Frontiers in Immunology.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

L. Notarangelo, J. Puck, T. Torgerson, 2019, Journal of Clinical Immunology.

A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders.

Michael J. Eckrich, A. Gennery, T. Olson, 2021, The Journal of allergy and clinical immunology.

The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions

L. Notarangelo, J. Puck, K. Sullivan, 2022, The Journal of allergy and clinical immunology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

L. Notarangelo, J. Puck, T. Torgerson, 2020, Journal of Clinical Immunology.

Mevalonic aciduria: Does stem cell transplant fully cure disease?

C. Ferreira, L. Jung, B. Loechelt, 2020, Pediatric transplantation.

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).

L. Notarangelo, J. Puck, T. Torgerson, 2019, The Journal of allergy and clinical immunology.

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

P. Hanley, C. Bollard, K. Mahadeo, 2022, Blood advances.

HSCT for PID: not just for children.

B. D. Dávila Saldaña, 2018, Blood.

High Rates of Community and Hospital Acquired Infections in Patients with Cellular Immunodeficiencies

B. Hanisch, M. Keller, Xiaoyan Song, 2018, Journal of Clinical Immunology.

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Elias T. Zambidis, S. Pai, P. Hanley, 2024, Nature communications.

Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.

J. Puck, T. Torgerson, S. Pai, 2024, Clinical immunology.

Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD.

L. Notarangelo, J. Puck, T. Torgerson, 2023, Blood.